Coloplast A/S (COLOb)

775.8
+19.8(+2.62%)
  • Volume:
    292,369
  • Bid/Ask:
    0.0/0.0
  • Day's Range:
    763.4 - 783.0

COLOb Overview

Prev. Close
756
Day's Range
763.4-783
Revenue
21.62B
Open
764
52 wk Range
728.8-1,194
EPS
22.48
Volume
292,369
Market Cap
164.71B
Dividend (Yield)
19.00
(2.45%)
Average Vol. (3m)
178,463
P/E Ratio
38.31
Beta
0.198
1-Year Change
-25%
Shares Outstanding
212,307,124
Next Earnings Date
Nov 07, 2022
What is your sentiment on Coloplast?
or
Market is currently closed. Voting is open during market hours.

Coloplast A/S News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Coloplast A/S Company Profile

Coloplast A/S Company Profile

Employees
12728
Market
Denmark
  • Type:Equity
  • Market:Denmark
  • ISIN:DK0060448595
  • S/N:198000000

Coloplast A/S is a Denmark-based company active within the healthcare sector. It is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The Company supplies products to hospitals, institutions as well as wholesalers and pharmacies.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuySellSell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong SellStrong Sell
  • Har lige udbetalt udbytte, så nu kommer den til at stige frem til nytår.
    0
    • Do you really think so, Hans?Considering the P/E ratio, Coloplast is really very expensive: at the level of luxury shares. It would seem very difficult to increase its value. I would be very happy, anyway ........ What do you think?
      0